These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21519245)

  • 1. Integrated surveillance of HIV care in low-income and middle-income countries.
    Tassie JM; Bertagnolio S; Souteyrand Y
    Curr Opin HIV AIDS; 2011 Jul; 6(4):233-8. PubMed ID: 21519245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening health systems through HIV monitoring and evaluation in Sub-Saharan Africa.
    Ekouevi DK; Karcher S; Coffie PA
    Curr Opin HIV AIDS; 2011 Jul; 6(4):245-50. PubMed ID: 21546830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead in the era of antiretroviral therapy.
    Wringe A; Cataldo F; Stevenson N; Fakoya A
    Health Policy Plan; 2010 Sep; 25(5):352-62. PubMed ID: 20144935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and future directions in HIV surveillance in low- and middle-income countries.
    Diaz T; Garcia-Calleja JM; Ghys PD; Sabin K
    Curr Opin HIV AIDS; 2009 Jul; 4(4):253-9. PubMed ID: 19532061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between AIDS and family planning programmes: a rationale for developing integrated reproductive health services.
    Pachauri S
    Health Transit Rev; 1994; 4 Suppl():321-47. PubMed ID: 10150523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future management of treatment failure in low- and middle-income countries.
    Boyd MA
    Curr Opin HIV AIDS; 2010 Jan; 5(1):83-9. PubMed ID: 20046152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global progress in PMTCT and paediatric HIV care and treatment in low- and middle-income countries in 2004-2005.
    Luo C; Akwara P; Ngongo N; Doughty P; Gass R; Ekpini R; Crowley S; Hayashi C
    Reprod Health Matters; 2007 Nov; 15(30):179-89. PubMed ID: 17938083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya.
    Chakaya JM; Mansoer JR; Scano F; Wambua N; L'Herminez R; Odhiambo J; Mohamed I; Kangangi J; Ombeka V; Akeche G; Adala S; Gitau S; Maina J; Kibias S; Langat B; Abdille N; Wako I; Kimuu P; Sitienei J
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):424-9. PubMed ID: 18371269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality standards in provision of facility based HIV care and treatment: a case study from Dar es Salaam Region, Tanzania.
    Mapunjo S; Urassa DP
    East Afr J Public Health; 2007 Apr; 4(1):12-8. PubMed ID: 17907755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
    Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV risk behavioral surveillance: a methodology for monitoring behavioral trends.
    Mills S; Saidel T; Bennett A; Rehle T; Hogle J; Brown T; Magnani R
    AIDS; 1998; 12 Suppl 2():S37-46. PubMed ID: 9792360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public-private mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles.
    Chakaya J; Uplekar M; Mansoer J; Kutwa A; Karanja G; Ombeka V; Muthama D; Kimuu P; Odhiambo J; Njiru H; Kibuga D; Sitienei J
    Int J Tuberc Lung Dis; 2008 Nov; 12(11):1274-8. PubMed ID: 18926037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.